This site is intended for the UK public
Biotest produces human plasma-derived concentrates for immunological disorders and hepatitis B which are available as a ready-to-use solution.
For the treatment of Haemophilia A and B, Biotest produces two human plasma-derived preparations which are designed for intravenous injection.
Biotest produces human plasma-derived concentrates for intensive care medicine for volume expansion or protein substitution.
You're about to leave biotest.gb and open an URL to %targeturl%, do you want to proceed?
